By InvitationNot Applicable

Prevalence of BK Viremia in Simultaneous Liver-Kidney Transplant

United States50 participantsStarted 2021-11-17

Plain-language summary

The human BK polyomavirus is a significant risk factor for renal transplant dysfunction and allograft loss. The prevalence of BK viremia (BKV) following kidney transplantation is estimated to be 10-20%.

Who can participate

Age range18 Years – 100 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age 18 years or older * SLK recipients transplanted at MDMC between 2015-2020 Exclusion Criteria: * Below 18 years of age * Patients who did not undergo SLK transplant at MDMC

What they're measuring

To characterize the prevalence of BKV in the SLK patient population at (Methodist Dallas Medical Center)MDMC.

Timeframe: over a 6-year period (2015 to 2020).

Trial details

NCT IDNCT05224583

SponsorMethodist Health System

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2027-11-17

View on ClinicalTrials.gov More Polyomavirus Infections trials